Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cook

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Nature|June 3, 2026
A natural depsipeptide antibiotic binds the E-site of the bacterial ribosomeManpreet Kaur, Dmitrii Y Travin, Max J Berger, et al.
Digestive Diseases and Sciences|December 26, 2024
Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data ResourceChen Yanover, Ramit Magen-Rimon, Erica A Voss, et al.
International Journal of Cancer|September 29, 2015
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinomaWeronica E Ek, Katarina Lagergren, Michael Cook, et al.
Research Square|November 24, 2025
Saskemycin, a potent and selective antimycobacterial agent targeting a unique site on the ribosomeGerard Wright, Michael Cook, Min Xu, et al.
The New England Journal of Medicine|May 7, 2025
Enhanced CAR T-Cell Therapy for Lymphoma after Previous FailureJakub Svoboda, Daniel J Landsburg, James Gerson, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Research Square|October 27, 2023
Heterogeneous genetic architectures and evolutionary genomics of prostate cancer in Sub-Saharan AfricaTimothy Rebbeck, Rohini Janivara, Wenlong Chen, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Nature|June 3, 2026
A natural depsipeptide antibiotic binds the E-site of the bacterial ribosomeManpreet Kaur, Dmitrii Y Travin, Max J Berger, et al.
Digestive Diseases and Sciences|December 26, 2024
Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data ResourceChen Yanover, Ramit Magen-Rimon, Erica A Voss, et al.
International Journal of Cancer|September 29, 2015
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinomaWeronica E Ek, Katarina Lagergren, Michael Cook, et al.
Research Square|November 24, 2025
Saskemycin, a potent and selective antimycobacterial agent targeting a unique site on the ribosomeGerard Wright, Michael Cook, Min Xu, et al.
The New England Journal of Medicine|May 7, 2025
Enhanced CAR T-Cell Therapy for Lymphoma after Previous FailureJakub Svoboda, Daniel J Landsburg, James Gerson, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Research Square|October 27, 2023
Heterogeneous genetic architectures and evolutionary genomics of prostate cancer in Sub-Saharan AfricaTimothy Rebbeck, Rohini Janivara, Wenlong Chen, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Pageof 8